Venus Remedies reports 28% rise in Q2 net profit

03 Nov 2012 Evaluate

Venus Remedies has reported results for second ended September 30, 2012.

The company has reported 28.42% rise in its net profit at Rs 15.09 crore for the quarter ended September 30, 2012 as compared to Rs 11.75 crore for the same quarter in the previous year.  Total income of the company has increased by 15.29% at Rs 110.81 crore for quarter under review as compared to Rs 96.11 crore for the quarter ended September 30, 2011.

Venus Remedies is a pharmaceutical manufacturing company. The company provides formulations in area of antibiotics and oncological therapeutics. The company has two manufacturing facilities located in India and Germany. It manufactures Oncological and Cefelosporine Injectable products.

Venus Remedies Share Price

322.00 33.75 (11.71%)
31-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1462.50
Dr. Reddys Lab 5784.50
Cipla 1451.25
Zydus Lifesciences 1001.15
Lupin 1587.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.